Today: 23 May 2026
S&P 500 2026 Forecast: 7,490 Target Meets a Data Test as Earnings Season Nears

S&P 500 2026 Forecast: 7,490 Target Meets a Data Test as Earnings Season Nears

NEW YORK, January 7, 2026, 06:01 EST — Premarket

  • U.S. labor-market data due this week include JOLTS on Jan. 7 and payrolls on Jan. 9; CPI follows on Jan. 13.
  • JPMorgan Chase is scheduled to post results and hold its earnings call on Jan. 13.

Strategists polled by Reuters see the S&P 500 at 7,490 by end-2026, implying gains of just over 9% from end-2025 as investors weigh Fed succession, election risk and the durability of the AI boom. A slim majority—56%—also forecast a market correction in the coming months. “The most under-appreciated tail risk for 2026 is that the Fed eases monetary policy more than economic conditions justify, inadvertently reigniting inflation,” said Lale Akoner, a global market strategist at eToro. Reuters

Wall Street closed higher on Tuesday, with the S&P 500 up 0.62% at 6,944.82, just under 7,000, while the Nasdaq rose 0.65% and the Dow gained 0.99% to a record. SanDisk jumped over 27% and Western Digital gained 17% after Nvidia CEO Jensen Huang spoke at CES, while Moderna rose almost 11% after BofA raised its price target. “We’re going to have a very strong earnings season for Big Tech,” said Jed Ellerbroek at Argent Capital, as the S&P 500 trades around 22 times expected earnings, about $22 per $1 of forecast profit, LSEG data show. Reuters

Investors get the next macro test at 10:00 a.m. ET on Wednesday, when the Job Openings and Labor Turnover Survey (JOLTS) for November is due. Friday’s employment report for December follows at 8:30 a.m. ET, and the consumer price index (CPI) for December — a key inflation gauge — is scheduled for Tuesday, Jan. 13 at 8:30 a.m. ET. The Bureau of Labor Statistics said some release dates remain subject to change after a lapse in government services.

Fourth-quarter earnings season starts in earnest next week, with U.S. bank results expected to set the tone on credit quality, trading and dealmaking. JPMorgan Chase (JPM.N) plans to release results at 7:00 a.m. ET on Tuesday, Jan. 13 and hold its earnings call at 8:30 a.m., the bank said.

Some investors are positioning for a broader 2026 U.S. stock market rally, looking beyond expensive tech leaders as rate cuts lower financing costs. “The big difference going into 2026 is that we finally are seeing earnings growth come back into small caps,” said Oren Shiran, a portfolio manager at Lazard Asset Management. Jefferies strategist Steven DeSanctis expects the Russell 2000 small-cap index to end 2026 at 2,825, and LSEG data compiled by Reuters show traders pricing two 25-basis-point, or quarter-point, Fed cuts this year. Reuters

But a stumble in inflation data or an earnings season that fails to justify AI spending could trigger profit-taking after the early-year run to records. Political and geopolitical shocks — from U.S. trade policy to overseas crises — also remain a wild card for risk assets.

With the S&P 500 near 7,000, traders will look for signs that gains can broaden beyond a narrow set of AI-linked winners. The bond market’s reaction to incoming labor data will matter as much as the headlines, because yields shape the discount rate investors use to value future profits.

The first test comes on Friday, Jan. 9, with the December jobs report at 8:30 a.m. ET. A weak reading would bolster expectations of faster easing, while a stronger one could keep pressure on valuation-sensitive stocks.

Stock Market Today

  • UBS Boosts Jazz Pharma Stock Price Target to $307 Ahead of FDA Decision
    May 23, 2026, 2:29 PM EDT. UBS upgraded Jazz Pharmaceuticals (JAZZ) stock from neutral to buy, raising its price target by 63% to $307 from $188. This surge exceeds the prior consensus of $242 and follows strong Q1 results, with revenue up 19% year-over-year and oncology portfolio growth of 45%. The move anticipates FDA approval on August 25 of Zanidatamab (Ziihera) for HER2-positive gastroesophageal cancer, expected to generate peak sales of $3.1 billion. UBS projects 10% revenue and 11% earnings growth from 2026-2030, versus consensus of around 7% and 6%, and supports a valuation multiple increase from 7x to 10x earnings, reflecting confidence in sustainable growth. Key risks include FDA delays, slower oncology sales ramp, and underperformance of core franchises like Xywav and Epidiolex.

Latest articles

AbbVie Shares Edge Up Ahead Of Holiday On Pipeline News

AbbVie Shares Edge Up Ahead Of Holiday On Pipeline News

23 May 2026
AbbVie shares closed Friday at $215.70, up 0.56%, gaining 2.5% for the week. The company reported a positive European panel recommendation for MAVIRET in acute hepatitis C and released new oncology data ahead of the ASCO meeting. U.S. markets are closed Monday for Memorial Day, with trading set to resume Tuesday.
Coherent Shares Trade Close to $378, With Next Test Set for Tuesday After Volatile AI-Optics Week

Coherent Shares Trade Close to $378, With Next Test Set for Tuesday After Volatile AI-Optics Week

23 May 2026
Coherent Corp. shares closed at $377.57 Friday, down 0.1% for the day and 1.3% below last week, underperforming the S&P 500 and Nasdaq ahead of the Memorial Day market closure. The company reported fiscal Q3 revenue of $1.81 billion, up 21% year-over-year, with strong demand in datacenter and communications. Nvidia invested $2 billion in March and signed a multi-year optics agreement. Coherent trades at 179 times trailing earnings.
Intuit Slashes 3,000 Jobs as TurboTax Faces New AI Threats

Intuit Slashes 3,000 Jobs as TurboTax Faces New AI Threats

23 May 2026
Intuit will cut about 3,000 jobs, or 17% of its workforce, and close offices in Reno and Woodland Hills as it restructures to focus on artificial intelligence. The company expects $300 million to $340 million in charges, mostly in the fiscal fourth quarter. Intuit raised full-year revenue guidance but lowered its TurboTax outlook, citing pressure from low-cost AI tools. Shares last traded at $319.94 after a volatile week.
Standard Chartered (STAN.L) stock slips as buyback and 2025 targets come into focus
Previous Story

Standard Chartered (STAN.L) stock slips as buyback and 2025 targets come into focus

Arctic Cat buys Quebec’s Widescape stand-up snowmobile maker as $13 million debt forces sale
Next Story

Arctic Cat buys Quebec’s Widescape stand-up snowmobile maker as $13 million debt forces sale

Go toTop